Home/Filings/4/0000950142-05-001941

4//SEC Filing

PERSEUS SOROS PARTNERS LLC 4

Accession 0000950142-05-001941

CIK 0001182129other

View on SEC.gov Company Profile

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 5:46 PM ET

Size

25.2 KB

Accession

0000950142-05-001941

Insider Transaction Report

Form 4

Period: 2005-06-30

AUXILIUM PHARMACEUTICALS INCAUXL

PEARL FRANK H

10% Owner

Transactions

Purchase
Warrants to Purchase Common Stock
2005-06-30+153,022→ 153,022 total
Exercise: $5.84Exp: 2010-06-30→ Common Stock (153,022 underlying)
Purchase
Common Stock
2005-06-30$4.90/sh+612,089$2,999,236→ 3,877,403 total

PERSEUS SOROS PARTNERS LLC

10% Owner

Transactions

Purchase
Common Stock
2005-06-30$4.90/sh+612,089$2,999,236→ 3,877,403 total
Purchase
Warrants to Purchase Common Stock
2005-06-30+153,022→ 153,022 total
Exercise: $5.84Exp: 2010-06-30→ Common Stock (153,022 underlying)

PERSEUS BIOTECH FUND PARTNERS LLC

10% Owner

Transactions

Purchase
Common Stock
2005-06-30$4.90/sh+612,089$2,999,236→ 3,877,403 total
Purchase
Warrants to Purchase Common Stock
2005-06-30+153,022→ 153,022 total
Exercise: $5.84Exp: 2010-06-30→ Common Stock (153,022 underlying)

PERSEUS SOROS BIOPHARMACEUTICAL FUND LP

10% Owner

Transactions

Purchase
Common Stock
2005-06-30$4.90/sh+612,089$2,999,236→ 3,877,403 total
Purchase
Warrants to Purchase Common Stock
2005-06-30+153,022→ 153,022 total
Exercise: $5.84Exp: 2010-06-30→ Common Stock (153,022 underlying)

SFM AH LLC

10% Owner

Transactions

Purchase
Warrants to Purchase Common Stock
2005-06-30+153,022→ 153,022 total
Exercise: $5.84Exp: 2010-06-30→ Common Stock (153,022 underlying)
Purchase
Common Stock
2005-06-30$4.90/sh+612,089$2,999,236→ 3,877,403 total

SFM PARTICIPATION LP

10% Owner

Transactions

Purchase
Common Stock
2005-06-30$4.90/sh+612,089$2,999,236→ 3,877,403 total
Purchase
Warrants to Purchase Common Stock
2005-06-30+153,022→ 153,022 total
Exercise: $5.84Exp: 2010-06-30→ Common Stock (153,022 underlying)

PERSEUSPUR LLC

10% Owner

Transactions

Purchase
Common Stock
2005-06-30$4.90/sh+612,089$2,999,236→ 3,877,403 total
Purchase
Warrants to Purchase Common Stock
2005-06-30+153,022→ 153,022 total
Exercise: $5.84Exp: 2010-06-30→ Common Stock (153,022 underlying)

SOROS FUND MANAGEMENT LLC

10% Owner

Transactions

Purchase
Warrants to Purchase Common Stock
2005-06-30+153,022→ 153,022 total
Exercise: $5.84Exp: 2010-06-30→ Common Stock (153,022 underlying)
Purchase
Common Stock
2005-06-30$4.90/sh+612,089$2,999,236→ 3,877,403 total

SOROS GEORGE

10% Owner

Transactions

Purchase
Common Stock
2005-06-30$4.90/sh+612,089$2,999,236→ 3,877,403 total
Purchase
Warrants to Purchase Common Stock
2005-06-30+153,022→ 153,022 total
Exercise: $5.84Exp: 2010-06-30→ Common Stock (153,022 underlying)

Footnotes (3)

[F1]All of the securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"). Perseus-Soros Partners, LLC, a Delaware limited liability company ("Perseus-Soros Partners"), is the general partner of Perseus-Soros. Perseus BioTech Fund Partners, LLC, a Delaware limited liability company ("Perseus Partners"), and SFM Participation, L.P., a Delaware limited partnership ("SFM Participation"), are the managing members of Perseus-Soros Partners. Perseuspur, L.L.C., a Delaware limited liability company ("Perseuspur"), is the managing member of Perseus Partners. Mr. Frank H. Pearl is the sole member of Perseuspur. SFM AH LLC, a Delaware limited liability company ("SFM AH"), is the general partner of SFM Participation. Soros Fund Management LLC ("SFM LLC") is the managing member of SFM AH. Mr. George Soros is the Chairman of SFM LLC.
[F2]Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), Perseus-Soros Partners, Perseus Partners, SFM Participation, Perseuspur , SFM AH, Mr. Pearl, SFM LLC and Mr. Soros are deemed to be beneficial owners of the shares beneficially owned by Perseus-Soros only to the extent of the greater of his or its respective direct or indirect interest in the profits or capital account of Perseus-Soros. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that Perseus-Soros Partners, Perseus Partners, SFM Participation, Perseuspur, SFM AH, Mr. Pearl, SFM LLC or Mr. Soros is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities owned by Perseus-Soros in excess of such amount.
[F3]Immediately.

Documents

2 files

Issuer

AUXILIUM PHARMACEUTICALS INC

CIK 0001182129

→

Entity typeother

Related Parties

filerCIK 0001250191

Filing Metadata

Form type: 4
Filed: Jul 4, 8:00 PM ET
Accepted: Jul 5, 5:46 PM ET
Size: 25.2 KB

View on SEC.gov